These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33794269)

  • 1. Engineering a sustained release vaccine with a pathogen-mimicking manner for robust and durable immune responses.
    Hou Y; Liu R; Hong X; Zhang Y; Bai S; Luo X; Zhang Y; Gong T; Zhang Z; Sun X
    J Control Release; 2021 May; 333():162-175. PubMed ID: 33794269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW; Tang SQ; Rong MZ; Zhang MQ
    Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum hydroxide colloid vaccine encapsulated in yeast shells with enhanced humoral and cellular immune responses.
    Liu H; Jia Z; Yang C; Song M; Jing Z; Zhao Y; Wu Z; Zhao L; Wei D; Yin Z; Hong Z
    Biomaterials; 2018 Jun; 167():32-43. PubMed ID: 29554479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogen-mimicking vaccine delivery system designed with a bioactive polymer (inulin acetate) for robust humoral and cellular immune responses.
    Kumar S; Kesharwani SS; Kuppast B; Bakkari MA; Tummala H
    J Control Release; 2017 Sep; 261():263-274. PubMed ID: 28669593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogen-Mimicking Polymeric Nanoparticles based on Dopamine Polymerization as Vaccines Adjuvants Induce Robust Humoral and Cellular Immune Responses.
    Liu Q; Jia J; Yang T; Fan Q; Wang L; Ma G
    Small; 2016 Apr; 12(13):1744-57. PubMed ID: 26849717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection.
    Hung CY; Zhang H; Castro-Lopez N; Ostroff GR; Khoshlenar P; Abraham A; Cole GT; Negron A; Forsthuber T; Peng T; Galgiani JN; Ampel NM; Yu JJ
    Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30104216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucan Particles Are a Powerful Adjuvant for the HBsAg, Favoring Antiviral Immunity.
    Soares E; Groothuismink ZMA; Boonstra A; Borges O
    Mol Pharm; 2019 May; 16(5):1971-1981. PubMed ID: 30964694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunopotentiator, ophiopogonin D, encapsulated in a nanoemulsion as a robust adjuvant to improve vaccine efficacy.
    Tong YN; Yang LY; Yang Y; Song Z; Peng LS; Gao JN; Zeng H; Zou QM; Sun HW; Mao XH
    Acta Biomater; 2018 Sep; 77():255-267. PubMed ID: 30031164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses.
    Hou Y; Wang Y; Tang Y; Zhou Z; Tan L; Gong T; Zhang L; Sun X
    J Control Release; 2020 Oct; 326():120-130. PubMed ID: 32585230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.
    Misiak A; Leuzzi R; Allen AC; Galletti B; Baudner BC; D'Oro U; O'Hagan DT; Pizza M; Seubert A; Mills KHG
    Vaccine; 2017 Sep; 35(39):5256-5263. PubMed ID: 28823618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems.
    Gordon S; Young K; Wilson R; Rizwan S; Kemp R; Rades T; Hook S
    J Liposome Res; 2012 Sep; 22(3):193-204. PubMed ID: 22188610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Injectable Pentablock Copolymer Based Thermoresponsive Hydrogels for Sustained Release Vaccines.
    Bobbala S; Tamboli V; McDowell A; Mitra AK; Hook S
    AAPS J; 2016 Jan; 18(1):261-9. PubMed ID: 26589309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
    Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O
    J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained-immunostimulatory nanocellulose scaffold to enhance vaccine efficacy.
    Nishiguchi A; Taguchi T
    J Biomed Mater Res A; 2020 May; 108(5):1159-1170. PubMed ID: 31990447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice.
    Grenfell RF; Shollenberger LM; Samli EF; Harn DA
    Clin Vaccine Immunol; 2015 Mar; 22(3):336-43. PubMed ID: 25609075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.